Allergan second-quarter contact lens care sales rise 10.7% to $103.6 mil..
This article was originally published in The Tan Sheet
ALLERGAN CONTACT LENS CARE SALES RISE 10.7% to $103.6 mil. in the second quarter and 9.2% to $195.1 mil. in the first half, the firm reported July 17. Excluding sales from Pilkington Barnes Hind, which Allergan acquired in the fourth quarter of 1995 ("The Tan Sheet" Dec. 4, 1995, p. 7), the segment was down 2.7% in the half; Pilkington Barnes Hind generated sales of $21.4 mil. during the six months
You may also be interested in...
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.